Get Appointment
AML Female Cancer Panel

AML Female Cancer Panel

$150.00

The AML Female Cancer Panel is a targeted blood test designed to monitor key tumor markers associated with female cancers. This panel provides valuable insights for cancer detection, treatment monitoring, and recurrence assessment, helping patients and clinicians make informed decisions about care and therapy. Markers Included: CA 15-3: Primarily used to track breast cancer progression…

Out of stock

Category:

Description

The AML Female Cancer Panel is a targeted blood test designed to monitor key tumor markers associated with female cancers. This panel provides valuable insights for cancer detection, treatment monitoring, and recurrence assessment, helping patients and clinicians make informed decisions about care and therapy.

Markers Included:

  • CA 15-3: Primarily used to track breast cancer progression and detect recurrence.

  • CA 125, Serum: A critical marker for ovarian cancer and other gynecological or non-gynecological malignancies.

  • CA 19-9: Commonly elevated in pancreatic, gastrointestinal, and certain gynecological cancers.

Clinical Applications:

  • Cancer Detection & Monitoring: Evaluates therapy effectiveness and tracks known malignancies.

  • Risk Assessment: Identifies potential recurrence or metastasis.

  • Post-Treatment Surveillance: Supports ongoing monitoring for patients after treatment.

Convenient Testing Options:
No doctor’s visit is required. Choose from at-home blood collection or visit our Patient Service Center (PSC) in Central Florida. For patients outside Central Florida, nationwide testing options are available, ensuring access wherever you are.

The AML Female Cancer Panel is an essential tool for proactive cancer care, supporting early intervention and personalized treatment strategies.

Related products